The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo

Polyhedron

Volumn 22, Issue 3, 2003, Pages 455-463

  Hepburn, Dion D D ^a   Burney, J Marcel ^a   Woski, Stephen A ^a   Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

8 OHdG; Chromium picolinate; DNA; Lipid peroxidation; Rats

Indexed keywords

CHROMIUM; LIPIDS; OXIDATION; OXIDATIVE STRESS; RATS;

8-OHDG; CATALYTIC FORMATION; CHROMIUM PICOLINATE; IN-VIVO; LIPID PEROXIDATION; NUTRITIONAL SUPPLEMENTS; OXIDATIVE DAMAGE; OXIDATIVE DNA DAMAGE; PICOLINATES; REACTIVE OXYGEN SPECIES;

DNA;

CHROMIUM PICOLINATE; DNA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA BINDING; DNA DAMAGE; KIDNEY; LIPID PEROXIDATION; LIVER; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0037322256     PISSN: 02775387     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-5387(02)01369-4     Document Type: Article

References (37)

1. D.M. Stearns, J.P. Wise, Sr., S.R. Patierno, K.E. Wetterhahn, FASEB J. 9 (1995) 1643.
2. D. Bagchi, M. Bagchi, J. Balmoori, X. Ye, S.J. Stohs, Res. Commun. Mol. Pathol. Pharmacol. 97 (1997) 335.
3. D.M. Stearns, J.J. Belbruno, K.E. Wetterhahn, FASEB J. 9 (1995) 1650.
4. J.K. Speetjens, R.A. Collins, J.B. Vincent, S.A. Woski, Chem. Res. Toxicol. 12 (1999) 483.
5. Y. Sun, J. Ramirez, S.A. Woski, J.B. Vincent, J. Biol. Inorg. Chem. 5 (2000) 129.
6. K.D. Sugden, R.D. Geer, S.J. Rogers, Biochemistry 31 (1992) 11626.
7. N.E. Chakov, R.A. Collins, J.B. Vincent, Polyhedron 18 (1999) 2891.
8. B. Gammelgaard, K. Jensen, B.J. Steffansen, J. Trace Elem. Med. Biol. 13 (1999) 82.
9. D.D.D. Hepburn, J.B. Vincent, Chem. Res. Toxicol. 15 (2001) 93.
10. S.A. Kareus, C. Kelley, H.S. Walton, P.C. Sinclair, J. Hazardous Mater. B84 (2001) 163.
11. I. Kato, J.H. Vogelman, V. Dilman, J. Karkoszka, K. Frenkel, N.P. Durr, N. Orentreich, P. Toniolo, Eur. J. Epidemol. 14 (1998) 621.
12. J.R. Komorowski, K. Loveday, J. Am. Coll. Nutr. 18 (1999) 527.
13. J. Cerulli, D.W. Grabe, I. Gauthier, M. Malone, M.D. McGoldrick, Ann. Pharmacother. 32 (1998) 428.
14. (a) W.G. Wasser, V.D. D'Agati, Ann. Int. Med. 126 (1997) 410;
15. See also (b) M.F. McCarty, Ann. Int. Med. 127 (1997) 654;
16. (c) J.N. Hathcock, Ann. Int. Med. 127 (1997) 655;
17. (d) H.J. Michenfelder, J. Thompson, M. Shepherd, Ann. Int. Med. 127 (1997) 655;
18. (e) B. Mennen, Ann. Int. Med. 127 (1997) 655;
19. (f) W.G. Wasser, V.D. D'Agati, Ann. Int. Med. 127 (1997) 656.
20. W.R. Martin, R.E. Fuller, Pharmacotherapy 18 (1998) 860.
21. J.F. Fowler, Jr., Cutis 65 (2000) 116.
22. J. Huszonek, Am. J. Pyschiatry 150 (1993) 1560.
23. P.C. Young, G.W. Turiansky, M.W. Bonner, P.M. Benson, J. Am. Acad. Dermatol. 41 (1999) 820.
24. R.I. Press, J. Geller, G.W. Evans, West. J. Med. 152 (1990) 41.
25. W.T. Johnson, P. Zhang, D.E. Bergstrom, Nucl. Acids Res. 25 (1997) 559.
26. Y. Sun, B.J. Clodfelder, A.A. Shute, T. Irvin, J.B. Vincent, J. Biol. Inorg. Chem. 7 (2002) 252.
27. J.A. Buege, S.D. Aust, Methods Enzymol. 52 (1978) 302.
28. H.G. Preuss, P.L. Grojec, S. Lieberman, R.A. Anderson, Clin. Nephrol. 47 (1997) 325-330.
29. S. Shibutai, M. Takeshita, A.P. Grollman, Nature 349 (1991) 431.
30. K.C. Cheng, D.S. Cahill, H. Kasai, S. Nishimura, L.A. Loeb, J. Biol. Chem. 267 (1992) 166.
31. R.A. Anderson, N.A. Bryden, M.M. Polansky, J. Am. Coll. Nutr. 16 (1997) 273.
32. R.A. Anderson, N.A. Bryden, M.M. Polansky, K. Gautschi, J. Trace Elem. Exp. Med. 9 (1996) 11.
33. D.D.D. Hepburn, J.B. Vincent, J. Inorg. Biochem., accepted for publication.
34. D. Rindgen, S.H. Lee, M. Nakajima, I.A. Blair, Chem. Res. Toxicol. 13 (2000) 846 (and references therein).
35. D.M. Stearns, S.M. Silveira, K.K. Wolf, A.M. Luke, Mutat. Res. 513 (2002) 135.
36. C. Witmer, E. Faria, H.-S. Park, N. Sadreih, E. Yurkow, S. O'Connell, A. Sirak, H. Schleyer, Environ. Health Perspect. 102 (Suppl. 3) (1994) 169.
37. F. Mirasol, Chem. Market Rep. 257 (2000) Feb. 14, 2000.